topotecan has been researched along with chitosan in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, N; Katti, DS | 1 |
| Bhanumathi, R; Bhattacharyya, A; Gunasekaran, P; Kannan, S; Murugan, C; Rayappan, K; Shanthi, K; Sivasubramanian, S; Thangam, R; Thirumurugan, R; Vivek, R | 1 |
| Aghajanpour, L; Amoli, FA; Atyabi, F; Delrish, E; Dinarvand, R; Ghassemi, F; Jabbarvand, M; Lashay, A; Soleimani, M | 1 |
| Gabbay, RS; Rubinstein, A | 1 |
| Erk, N; Kanberoglu, GS; Mehmandoust, M; Pourhakkak, P; Soylak, M; Tiris, G; Zahmakiran, M | 1 |
5 other study(ies) available for topotecan and chitosan
| Article | Year |
|---|---|
Poly(d,l-lactide-co-glycolide)-chitosan composite particles for the treatment of lung cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Synergism; Humans; Lactic Acid; Lung Neoplasms; Nanocomposites; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Topotecan | 2015 |
Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy.
Topics: Acrylic Resins; Antineoplastic Combined Chemotherapy Protocols; Chitosan; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Nanoparticles; Oligopeptides; Quercetin; Silicon Dioxide; Topotecan; Triple Negative Breast Neoplasms | 2016 |
Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.
Topics: Animals; Antineoplastic Agents; Calorimetry, Differential Scanning; Chitosan; Drug Carriers; Flow Cytometry; Humans; Intravitreal Injections; Male; Nanoparticles; Neoplasm Transplantation; Particle Size; Rats; Rats, Wistar; Retinal Neoplasms; Retinoblastoma; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Topoisomerase I Inhibitors; Topotecan; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured; X-Ray Diffraction | 2021 |
Synchronizing the release rates of topotecan and paclitaxel from a self-eroding crosslinked chitosan - PLGA platform.
Topics: Calcium Chloride; Chitosan; Hydrogels; Paclitaxel; Topotecan; Water | 2022 |
An electrochemical sensing platform with a molecularly imprinted polymer based on chitosan-stabilized metal@metal-organic frameworks for topotecan detection.
Topics: Carbon; Chitosan; Electrochemical Techniques; Gold; Humans; Limit of Detection; Metal Nanoparticles; Metal-Organic Frameworks; Molecular Imprinting; Molecularly Imprinted Polymers; Polymers; Topotecan | 2023 |